Unknown

Dataset Information

0

Reconstitution of TCA cycle involving l-isoleucine dioxygenase for hydroxylation of l-isoleucine in Escherichia coli using CRISPR-Cas9.


ABSTRACT: l-isoleucine dioxygenase (IDO) is an Fe (II)/α-ketoglutarate (α-KG)-dependent dioxygenase that specifically converts l-isoleucine (l-Ile) to (2S, 3R, 4S)-4-hydroxyisoleucine (4-HIL). 4-HIL is an important drug for the treatment and prevention of type 1 and type 2 diabetes but the yields using current methods are low. In this study, the CRISPR-Cas9 gene editing system was used to knockout sucAB and aceAK gene in the TCA cycle pathway of Escherichia coli (E. coli). For single-gene knockout, the whole process took approximately 7 days. However, the manipulation time was reduced by 2 days for each round of gene modification for multigene editing. Using the genome-edited recombinant strain E. coli BL21(DE3) ΔsucABΔaceAK/pET-28a(+)-ido (2Δ-ido), the bioconversion ratio of L-Ile to 4-HIL was enhanced by about 15% compared to E. coli BL21(DE3)/pET-28a(+)-ido [BL21(DE3)-ido] strain. The CRISPR-Cas9 editing strategy has the potential in modifying multiple genes more rapidly and in optimizing strains for industrial production.

SUBMITTER: An J 

PROVIDER: S-EPMC7070131 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Reconstitution of TCA cycle involving l-isoleucine dioxygenase for hydroxylation of l-isoleucine in <i>Escherichia coli</i> using CRISPR-Cas9.

An Jianhong J   Zhang Wenli W   Jing Xiaoran X   Nie Yao Y   Xu Yan Y  

3 Biotech 20200313 4


l-isoleucine dioxygenase (IDO) is an Fe (II)/α-ketoglutarate (α-KG)-dependent dioxygenase that specifically converts l-isoleucine (l-Ile) to (2S, 3R, 4S)-4-hydroxyisoleucine (4-HIL). 4-HIL is an important drug for the treatment and prevention of type 1 and type 2 diabetes but the yields using current methods are low. In this study, the CRISPR-Cas9 gene editing system was used to knockout <i>sucAB</i> and <i>aceAK</i> gene in the TCA cycle pathway of <i>Escherichia coli</i> (<i>E. coli</i>). For  ...[more]

Similar Datasets

| S-EPMC10180240 | biostudies-literature
| S-EPMC4538657 | biostudies-other
| S-EPMC3684760 | biostudies-literature
| S-EPMC8654791 | biostudies-literature
| S-EPMC10715208 | biostudies-literature
| S-BSST1268 | biostudies-other
| S-EPMC5462464 | biostudies-literature
| S-EPMC2680622 | biostudies-other
| S-EPMC5979566 | biostudies-literature
| S-EPMC8203979 | biostudies-literature